In conclusion, we computationally designed and experimentally identified a novel synthesized ERK inhibitor (BL-EI001) that could induce apoptosis by the mitochondrial pathway but not dependent on Ras/Raf/MEK pathway in breast cancer cells. Here, RAF1 is linked to breast carcinoma.